Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.
By H. Whiteford, L. Degenhardt, J. Rehm, A. Baxter, A. Ferrari, H. Erskine, F. Charlson, Rosana E Norman, Abraham D. Flaxman, N. Johns and 3 more. The Lancet, 2013
5,237 citations recorded by the source corpus.
Subfields: Psychiatry and Mental health, Public Health, Environmental and Occupational Health, Social Psychology
View Paper: https://www.semanticscholar.org/paper/08e50d1cc59a1d9c1a0d21dfe9667e243aa1094d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Psychiatry and Mental health
- Carsten B. Pedersen
- R. McCutcheon
- Daniel R. Weinberger
- P. Mortensen
- I. Myin‐Germeys
- A. M. Dale
- J. Stone
- N. Millet
In Public Health, Environmental and Occupational Health
- Theo Vos
- Mark I. McCarthy
- Brendon Stubbs
- Douglas F. Levinson
- Gustavo Turecki
- A. Ferrari
- Dan J Stein
- H. Whiteford
In Social Psychology
- Merete Nordentoft
- N. Millet
- Helena Nguyen
- I. Myin‐Germeys
- James G. Scott
- Anne Cleary
- J. van Os
- John R. Crawford
Citations in the corpus
- A systematic review of reviews on the prevalence of anxiety disorders in adult populations (2016, neutral): “(Whiteford et al. 2013).”
- The Lancet Commission on global mental health and sustainable development. (2018, background): “91 SDG 5 (Gender equality) is particularly relevant for this domain.”
- Glutamate and dopamine in schizophrenia: an update for the 21st century (2015, background): “Schizophrenia is a common, severe mental illness (Jablensky, 2000; Jablensky et al., 1992), and a leading cause of adult disease burden (Whiteford et al., 2013).”